Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06ECM
|
|||
Former ID |
DIB001800
|
|||
Drug Name |
HBN-2
|
|||
Indication | Neurological disorder [ICD-11: 6B60] | Investigative | [1] | |
Company |
University of North Carolina
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Neurotensin receptor type 1 (NTSR1) | Target Info | Modulator | [1] |
KEGG Pathway | Calcium signaling pathway | |||
Neuroactive ligand-receptor interaction | ||||
Reactome | Peptide ligand-binding receptors | |||
G alpha (q) signalling events | ||||
WikiPathways | GPCRs, Class A Rhodopsin-like | |||
Gastrin-CREB signalling pathway via PKC and MAPK | ||||
Peptide GPCRs | ||||
GPCR ligand binding | ||||
GPCR downstream signaling | ||||
GPCRs, Other |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 309). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.